
Oncology & Hematology




March 24, 2025
inMIND Trial: Tafasitamab Plus Lenalidomide and Rituximab in Relapsed or Refractory Follicular Lymphoma
The ASCO Post
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.

March 24, 2025
New Reports Assess Oncology Workforce Well-Being, Propose Solutions to Address Burnout
The ASCO Post


March 21, 2025
Colorectal Cancer May Be Linked to Heightened Risk of Cardiovascular Mortality
The ASCO Post

Advertisement
Recommendations
Advertisement